Tikleen 90 Tablet

产品概览

About Tikleen 90 Tablet

Tikleen 90 Tablet is a medication containing the active ingredient ticagrelor, classified as P2Y12 Platelet Inhibitor. Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Ticagrelor is a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

ticagrelor, the active ingredient in Tikleen 90 Tablet, belongs to the P2Y12 Platelet Inhibitor class. 1 INDICATIONS AND USAGE Ticagrelor is a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Tikleen 90 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Tikleen 90 Tablet for extended periods without medical advice.